mTORC2 Phosphorylation of GSDME‐N Drives Cullin4B‐Mediated Proteasomal Degradation to Suppress Pyroptosis and Confer Radioresistance in Small Cell Lung Cancer
Advanced Science · 2026
DOI: 10.1002/advs.75844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Qing-Qing Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Cli…. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Cullin Proteins, Lung Neoplasms, Pyroptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Radioresistance is a main reason for treatment failure in patients with small cell lung cancer (SCLC). Consequently, it is important to determine the key mechanism and explore effective strategies to prevent SCLC radioresistance. We use an unbiased CRISPR screen to identify GSDME, a member of the Gasdermin (GSDM) family, as a critical driver of radiosensitivity in SCLC. Furthermore, we identify mTORC2 facilitates SCLC radioresistance by inhibiting GSDME‐N‐mediated pyroptosis. Mechanistically, mTORC2 phosphorylates GSDME‐N at serine 114 (S114), promoting the recruitment of the CUL4B‐RBBP4 E3 ubiquitin ligase complex. This complex mediates K48‐linked ubiquitination of GSDME‐N at lysine 41 (K41), leading to its proteasomal degradation. Clinically, elevated mTORC2 is linked to an unfavorable prognosis in SCLC patients. The study reveals mTORC2 phosphorylates GSDME‐N and promotes its Cullin4B‐mediated proteasomal degradation to suppress pyroptosis and drive radioresistance in SCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center…
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
- United Laboratory of Frontier Radiotherapy Technology of Sun Yat-Sen University & Chinese Academy of Sciences Ion Medical Technology Co, Guangzhou, Guangdong, P. R. China.
- VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
ORCID-Profile: Yuan-Yuan Chen, Xuan Li, Ming Chen
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Cancer Innovative Research Program
- Guangzhou Science and Technology Basic and Applied Basic Research Project
- Clinical Research 5010 Program
- National Natural Science Foundation of China
Zitieren
APA
Xu, Q. Q., Sun, C. M., Zhang, S. X., Li, R., Wu, C. F., Lin, Z. S., Li, L., Chen, R. Z., Li, Q. W., Chen, Y. Y., Li, X., & Chen, M. (2026). mTORC2 Phosphorylation of GSDME‐N Drives Cullin4B‐Mediated Proteasomal Degradation to Suppress Pyroptosis and Confer Radioresistance in Small Cell Lung Cancer. Advanced Science. https://doi.org/10.1002/advs.75844
Vancouver
Xu QQ, Sun CM, Zhang SX, Li R, Wu CF, Lin ZS, et al. mTORC2 Phosphorylation of GSDME‐N Drives Cullin4B‐Mediated Proteasomal Degradation to Suppress Pyroptosis and Confer Radioresistance in Small Cell Lung Cancer. Advanced Science. 2026. doi:10.1002/advs.75844
BibTeX
@article{Xu2026,
author = {Xu, Qing-Qing and Sun, Ci-Ming and Zhang, Sui-Xian and Li, Rui and Wu, Chen-Fei and Lin, Zai-Shan and Li, Li and Chen, Run-Zhe and Li, Qi-Wen and Chen, Yuan-Yuan and Li, Xuan and Chen, Ming},
title = {mTORC2 Phosphorylation of GSDME‐N Drives Cullin4B‐Mediated Proteasomal Degradation to Suppress Pyroptosis and Confer Radioresistance in Small Cell Lung Cancer},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75844}
}
EUVIMED